Vaccination strategies for emerging disease epidemics of livestock

The Veterinary Clinics of North America. Food Animal Practice
D Scott McVey, Jishu Shi

Abstract

Well-designed immunization programs have an important role in the control of disease outbreaks in cattle. The success of these immunization programs depends on the coordinated and effective use of an efficacious vaccine along with other required control measures. Efforts to improve key characteristics of vaccines (such as onset of immunity, duration of immunity, and basic safety and efficacy) will allow greater utility of the vaccines for outbreak control.

References

Aug 8, 1992·The Veterinary Record·A I Donaldson, T R Doel
Oct 1, 1980·The Journal of Infectious Diseases·P F Wehrle
May 1, 1993·The British Veterinary Journal·J S Salt
Feb 27, 1998·The Veterinary Quarterly·R J GerritsenG R Rutteman
Oct 6, 2000·Research in Veterinary Science·S C Howard, C A Donnelly
Jan 1, 2003·Nature·M J KeelingB T Grenfell
Jan 16, 2003·Virus Research·T R Doel
Jun 5, 2003·International Journal for Parasitology·David Scott McVeySteven C Olson
Jun 18, 2004·Emerging Infectious Diseases·Mirjam KretzschmarJan van Wijngaarden
Mar 5, 2005·Applied and Environmental Microbiology·D C DragonN Woollen
Aug 29, 2006·Vaccine·Xiao-Nan Dong, Ying-Hua Chen
Nov 28, 2006·Vaccine·Paul KitchingRobert Heckert
Apr 10, 2008·Transboundary and Emerging Diseases·K De ClercqD K MacKay

❮ Previous
Next ❯

Citations

Jan 10, 2012·Transboundary and Emerging Diseases·Emilio A León
Mar 20, 2013·International Immunopharmacology·Man-fei LiangRui-liang Zhu
Feb 28, 2016·Transboundary and Emerging Diseases·G K SharmaB Pattnaik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Related Papers

Biologicals : Journal of the International Association of Biological Standardization
Jean-Louis Virelizier
Proceedings of the National Academy of Sciences of the United States of America
Nami McCartyHarvey Cantor
© 2021 Meta ULC. All rights reserved